MOTS-c
Research chemical · Grade C
Goals
mitochondria, longevity, weight-loss, muscle
Evidence
0 RCT / 12 animal / 0 in vitro
Routes
injectable-sc
WADA
S4
FDA
Not approved
Cancer caution
caution
Typical dose
—
Half-life
Plasma half-life is estimated at approximately 30-60 minutes in animal models, but human clearance has not been measured
Primary mechanism
Mechanism diagram showing the compound's primary signaling pathway and downstream effects.